Skip to content

Study · Not a test of the peptide alone · 1994

1 result

Opening of frog skin sodium channels by phenobarbital.

Fonseca PD, Moura TF, Ferreira KT

Archives internationales de pharmacodynamie et de therapie1 Jul 1994

PMID7893187 (opens in a new tab)PepBankPUB-07893187

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Oxytocin.

  1. 01LabNot a test of Oxytocin aloneEx vivo tissueMechanism

    In isolated frog skin, phenobarbital caused the same percentage increase in short-circuit current in control and oxytocin-pretreated skins.

    In plain wordsIn lab tests on frog skin, phenobarbital raised current by the same percentage with or without oxytocin pretreatment.

    Peptide
    Oxytocin
    Outcome
    No significant changePhenobarbital-induced short-circuit current increase in oxytocin-pretreated skin
    Study

    frogn: not reported in source

    isolated frog skin
    Comparator
    Control skin
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    The results show that phenobarbital causes the same percentage of increase in Isc in control and oxytocin-pretreated skins.
    1 context sentence
    Summary · context
    To further characterize these channels, comparative studies with oxytocin (a hormone that opens amiloride-sensitive Na+ channels in the apical side) were performed.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:52 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.